WBD: The Arb Wall Street Mispriced

The Opening Thesis

The most dangerous arbitrage in media right now is not one where the deal breaks. It is one where the deal closes — just slowly enough to destroy the buyer in the process.

Wall Street has spent the summer debating whether twelve state attorneys general can beat Paramount Skydance in a federal courtroom in Oakland. That is a reasonable legal question. It is the wrong investment question. The right one is simpler and more urgent: can David Ellison afford to wait?

Starting October 1, Paramount owes Warner Bros. Discovery shareholders $7 million per day for every day the $111 billion merger remains unclosed. The trial is scheduled to begin March 2, 2027. The merger agreement expires June 4, 2027. A break fee of $7 billion sits behind it. Oracle, the Ellison family’s primary financial engine, has seen its credit rating cut to one notch above junk, its stock collapse from $240 to roughly $126 since June, and its free cash flow turn deeply negative as it burns capital on AI infrastructure. The acquirer’s balance sheet is cracking — and the clock hasn’t even started yet.

This is not a legal thesis. It is a financial one. And for investors positioned in WBD, the distinction matters enormously.

The Market Opportunity

Warner Bros. Discovery shares closed around $27.88 on August 13. The all-cash takeout price is $31 per share. That is a spread of roughly 11% — but the spread compresses further when you include the ticking fee, which begins accumulating at $0.25 per share per quarter starting October 1. A deal that closes in mid-March 2027, five days after the trial concludes on March 19, would deliver approximately $0.50 per share in additional cash on top of the $31 base. Total potential value: roughly $31.50.

Annualized, that return is attractive. The arb community has not abandoned the long side. What has changed is the shape of the risk.

The opportunity exists because the market is pricing two distinct scenarios simultaneously: a deal that closes at or near $31 plus the ticking fee, and a deal that collapses entirely — leaving WBD to trade as a standalone business against a $7 billion termination fee windfall that Paramount may or may not be able to pay. The spread between those two outcomes is wide. The market has not resolved it. That gap is where the investment decision lives.

Why This Company

WBD is not simply a passive target. It is the only position in this situation that wins in multiple scenarios.

If the deal closes: WBD shareholders receive $31 per share plus accumulated ticking fees — a return of 14% or more from current prices depending on timing, with cash certainty and no execution risk on the operating business.

If the deal breaks: WBD is entitled to the $7 billion regulatory termination fee. With roughly 2.6 billion shares outstanding, that represents approximately $2.69 per share in cash that flows directly to WBD. A standalone WBD, after four years of restructuring, entered Q2 2026 with streaming revenue exceeding $3 billion for the first time in company history, streaming EBITDA of $512 million (a 63% improvement year over year), a nearly 17% streaming EBITDA margin, and gross debt of $33.1 billion after refinancing $15 billion in bridge financing. The floor is not zero. It is not even close.

Paramount, by contrast, wins or loses everything on deal closure. If it closes: years of ticking fees, $7 billion in debt service for the break fee risk backstop, and the task of integrating two deeply leveraged legacy media businesses at the worst possible moment for linear advertising. If it breaks: Paramount owes $7 billion it may struggle to fund, facing a media business still reliant on linear networks whose ad revenue is in structural decline.

Among the publicly traded positions in this situation, WBD is the only security that holds asymmetric optionality regardless of the legal outcome.

Competitive Advantage and Business Quality

The market often treats WBD as a legacy media company in terminal decline. The Q2 2026 results complicate that framing.

Streaming is the story. Revenue crossed $3 billion in a single quarter for the first time, with subscriber-related revenue growth accelerating 200 basis points sequentially. EBITDA in the segment surged more than 60% year over year. CEO David Zaslav said on the August earnings call that the company expects 2026 to be its best year ever for subscriber retention — driven by bundling partnerships with Disney and Verizon that are suppressing churn. HBO continued to lead the industry with 150 Emmy nominations, including 122 for Max. Series including The Pitt, House of the Dragon, A Knight of the Seven Kingdoms, and Euphoria each averaged at least 25 million global viewers per episode in the first half of 2026.

The weakness is real but well understood. Total Q2 revenue fell 11% year over year to $8.72 billion, missing analyst estimates of $9.18 billion. Linear advertising revenue dropped nearly 30%, driven largely by the loss of NBA rights. Studio performance disappointed against a light film slate. International advertising weakened under geopolitical pressure.

The forward studio pipeline is where independent-scenario bulls point. WBD is producing 14 theatrical films in 2026 and plans to ramp to 19 in 2027, with a tentpole-heavy calendar that includes Lord of the Rings, Batman, Superman, and Minecraft 2. If the deal closes late or breaks entirely, that slate arrives under a WBD operating structure that is structurally better than at any point since the 2022 Discovery merger.

The Financial Trap: A Deal That Costs More Every Morning

The ticking fee is the central mechanism every investor in this situation must model. It begins October 1 and runs at $7 million per day until close. The trial is scheduled March 2 through March 19. After findings of fact are submitted by April 5, a ruling realistically arrives in April or May at the earliest.

The math by quarter:

• Q4 2026 (Oct. 1 through Dec. 31): Approximately $650 million in ticking fee liability accrues to Paramount
• Q1 2027 (Jan. 1 through March 31): Approximately $650 million more
• Total by trial conclusion (March 19): Roughly $1.2 billion owed, payable upon close
• Deal expiration: June 4, 2027 — the date WBD can walk if the agreement has not been extended
• Break fee: $7 billion due from Paramount if the transaction fails to close due to antitrust or regulatory reasons

Variety reported that a delay running to June 2027 could add roughly $1.7 billion to the total deal price. That is $1.7 billion Paramount must fund on top of the $2.8 billion already paid to Netflix when Netflix walked away from its prior agreement with WBD in February 2026.

Now add the Oracle dimension. S&P Global cut Oracle’s credit rating to BBB-, one step above junk. Five-year credit default swaps on Oracle debt reached a near 18-year high earlier this summer. Oracle’s AI infrastructure buildout drove free cash flow to negative $24 billion, and the company carries more than $100 billion in total debt, having issued $18 billion in new notes in September 2025 alone. Larry Ellison owns 41% of Oracle. Its stock is down more than 47% from its June peak. The family balance sheet that is backstopping this bid looks considerably less stable than it did in February when the deal was announced.

The arb market is not wide because traders expect the states to win in court. It is wide because traders are genuinely uncertain whether David Ellison can close this deal before the financial structure underneath it collapses.

The Regulatory Landscape

The federal case is largely resolved in Paramount’s favor. The DOJ closed its review in June without requiring divestitures or behavioral remedies. The EU cleared the deal with a minor concession: Paramount agreed to exit its United International Pictures film distribution joint venture with Universal in Europe. Paramount reports clearance from 65 jurisdictions globally, including Australia, Brazil, Canada, China, and the UK.

What remains is a coalition of twelve state attorneys general, led by California AG Rob Bonta, who filed suit in July 2026 on the theory that the merger would harm competition in three markets: basic cable, tentpole theatrical releases, and wide-release theatrical distribution. The Writers Guild of America joined as a co-plaintiff in a separate action, subsequently consolidated before Judge Araceli Martinez-Olguin in the Northern District of California.

Judge Martinez-Olguin’s conduct to date has not favored Paramount’s timeline. She granted a temporary restraining order, extended it, set a trial date of March 2, 2027 — closer to the AGs’ April proposal than Paramount’s November request — and rejected an expedited schedule that would have reduced Paramount’s ticking fee exposure. An April 5, 2027 deadline for post-trial findings has been set, meaning a ruling realistically arrives in late spring at best.

Paramount’s legal defense rests on the argument that cable is a dying distribution system whose declining subscriber base renders competitive harm implausible, and that the combined streaming footprint creates efficiencies that benefit consumers. The AT&T-Time Warner precedent is Paramount’s reference point: the DOJ lost that case in 2018. But this is a state-led challenge, a different plaintiff class with a different track record, and the judge has already shown she is not inclined to move at Paramount’s preferred pace.

The Escalation

This week, Paramount escalated. David Ellison told his senior executive team on August 5 that Paramount will begin relocating its operations out of California on October 1 — the same day the ticking fee begins — unless Bonta agrees to settlement talks before then. Tennessee, Texas, and Georgia have reportedly offered relocation incentives. Ellison has outlined a five-year plan to shift most studio jobs out of the state, and has floated the possibility of selling the Paramount Studios and Warner Bros. Studio lots in Los Angeles.

Bonta called it blackmail. Lightshed Partners’ Richard Greenfield, one of the most closely followed media analysts, wrote that Paramount’s approach is making things worse and that the state AGs have no intention of settling. Meanwhile, industry voices including former HHS Secretary Xavier Becerra, DGA, and IATSE have publicly called for a negotiated resolution — suggesting that the settlement path, while narrow, is not entirely closed.

There is one new development that shifts the calculus: the parties filed a joint case management statement this week indicating they are engaged in constructive discussions to identify magistrate judges to preside over a settlement conference. That is not a settlement. But it is the first procedural signal that both sides are at least evaluating an off-ramp. Settlement discussions would be the single most significant near-term catalyst for the WBD position.

Forward Scenarios

Bull Case — Negotiated Settlement (Probability: 30%): Bonta accepts a consent decree with structural or behavioral remedies (likely some combination of content licensing commitments, distribution guarantees, and possibly a cable channel divestiture). The deal closes before the June 4, 2027 expiration. WBD shareholders receive $31 plus one to two quarters of ticking fees, implying a total value of $31.25 to $31.50 per share — a 12% to 13% return from current levels, delivered in three to seven months. This is the scenario where Ellison’s California relocation threat functions as genuine leverage rather than theater.

Base Case — Trial, Paramount Wins, Deal Closes (Probability: 40%): The trial runs March 2 through March 19. The judge rules for Paramount in April or May. The deal closes before June 4. WBD receives $31 plus approximately $1.5 billion in ticking fees distributed across all shares — total value roughly $31.50 per share. The base case is positive for WBD holders but extracts maximum financial pain from Paramount, whose $1.2-plus billion in ticking fee liability now sits alongside $33 billion in WBD gross debt on a combined balance sheet already stressed by Oracle’s deteriorating credit.

Bear Case — Deal Collapse (Probability: 30%): The trial concludes, a ruling comes in April or May, and either Paramount loses or the merger agreement expires before the ruling arrives. WBD receives the $7 billion regulatory termination fee — approximately $2.69 per share — but reverts to standalone trading. With gross debt at $33.1 billion and linear advertising in structural decline, a standalone WBD likely trades well below its current price absent the merger premium. The $7 billion fee provides a meaningful cushion but does not fully offset the premium collapse. Downside from current levels in a clean break scenario: 25% to 35%, net of the termination fee distribution.

Technical Overlay

WBD has traded between $10.79 and $30.00 over the past 52 weeks. The $30 level — reached briefly when the deal was first announced — represents the ceiling of the arb range and the approximate takeout value before ticking fee additions. Current price near $27.88 sits in the middle of the post-announcement range.

Volume has contracted from a 23 million share daily average toward the 13 million share range in recent sessions, consistent with the stock being predominantly held by arbitrageurs who have sized positions and are waiting rather than trading. A settlement announcement would spike volume and likely push shares to $30 or above within hours. A deal collapse announcement would gap the stock down to the $18 to $20 range — the approximate standalone trading value adjusted for the termination fee — in a single session.

This is a binary instrument. There is no meaningful technical analysis for a stock whose primary value driver is a legal calendar. Position sizing should reflect that.

What Investors Should Watch

• Settlement conference appointment: The parties are currently discussing magistrate judge candidates for a settlement conference. Any formal announcement of a settlement conference date is the most bullish near-term catalyst available.
• October 1 ticking fee start: Whether Paramount begins paying — and whether it simultaneously makes a public move on California relocation — will signal whether this is negotiating leverage or a genuine strategic decision.
• Oracle credit developments: Moody’s currently holds a Baa2 rating with a negative outlook on Oracle. A downgrade to below investment grade would materially increase market doubt about the Ellison family’s ability to fund both the ticking fee and the ultimate acquisition price.
• Judge Martinez-Olguin’s pretrial rulings: The final pretrial conference is February 24, 2027. Any summary judgment motion or pretrial ruling that narrows the states’ claims would meaningfully reduce the probability of a deal collapse.
• WBD Q3 2026 earnings: Streaming momentum needs to hold. If Max subscriber growth decelerates or studio performance deteriorates further while the deal drags, the standalone floor estimate drops — and so does the deal-break recovery value.
• June 4, 2027 expiration: This date determines whether the trial ruling comes in time. If Paramount and WBD do not extend the agreement and the ruling lands after June 4, WBD can walk. That scenario — a WBD-initiated termination after a Paramount legal victory — would be the most legally complex and financially damaging outcome for all parties.

The Risks Skeptics Are Right About

Before committing capital, the investment committee challenged its own thesis.

The bear case on WBD as an arb is not primarily legal. It is financial. If Oracle’s credit deterioration forces a Ellison capital call — whether through margin pressure on pledged shares, covenant triggers on Oracle’s $108 billion debt load, or difficulty raising the incremental capital needed to fund a delayed close — the deal could break not because the states won in court but because the buyer could not complete the financing. That scenario produces the worst possible outcome for WBD: no deal, no termination fee (because the break would not be antitrust-driven), and a reversion to standalone trading.

The merger agreement’s $7 billion regulatory termination fee is payable specifically if the deal fails to close due to antitrust or regulatory reasons. A buyer-side financing failure is not a regulatory termination event. That distinction could eliminate the primary downside protection for WBD holders in a break scenario.

WBD’s own fundamentals are also a risk. Total Q2 revenue declined 11% year over year. Net income collapsed 91% year over year to $149 million. Linear ad revenue fell nearly 30%. Gross debt stands at $33.1 billion. A standalone WBD that loses the merger premium, does not receive the termination fee, and continues to face structural linear decline would trade considerably lower than today’s price.

Bottom Line

The debate over this deal has been almost entirely framed around the legal question. Will the state AGs prevail? Do they have a winning antitrust theory? Can Paramount’s defense overcome the precedent concerns the judge has already surfaced?

Those are meaningful questions. They are not the determining ones.

What determines the next move for WBD is not the trial outcome. It is whether a settlement materializes before October 1 — and whether the settlement conference discussions reported this week represent genuine bilateral interest or procedural theater. A settlement before the ticking fee clock starts is the highest-probability path to maximum value for WBD shareholders and maximum financial relief for Paramount. The conditions for one exist. The political will, as of today, remains uncertain.

For investors with a multi-quarter horizon and the risk tolerance to hold a binary instrument, WBD at $27.88 represents a position with a plausible 12% to 14% return in a deal-close scenario and a 25% to 35% downside in a clean break. The ticking fee adds approximately $0.25 per share in value for every quarter of delay before a close — converting the wait itself into a yield-generating mechanism, as long as the buyer remains solvent.

The buyer’s solvency is the variable the market has not yet priced correctly. That is the edge.

For informational purposes only.